David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, talks about the increase of eosinophilic esophagitis, or EoE, along with other allergic conditions.
David R. Stukus, MD, FACAAI, of Nationwide Children's Hospital and The Ohio State University College of Medicine, and a board member of the American College of Allergy, Asthma & Immunology, discusses the rise of eosinophilic esophagitis.
Transcript
Eosinophilic esophagitis (EoE), despite being considered a rare disease, is going up in prevalence among children and adults, especially males. What could be some reasons behind this discrepancy?
It’s probably in large part due to improved recognition and diagnostic criteria. This is something that really didn't have a consensus definition until 15 years ago. So now as more people are recognizing it and know how to diagnose it, I think you're just going to naturally increase the number of people diagnosed with it. So that's probably part of it. Part of it also may just be that we still don't fully understand why some people develop EoE or allergies. There's a genetic predisposition that tends to tie in with various types of exposures; we’re seeing increased rise of food allergy and other allergic conditions, so EoE probably just falls along in that category as well. So, no easy answers, but it's nice to see more people dedicating their research to it and better understanding this this condition.
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
Real-World Evidence Confirms the Benefits of JAK Inhibitors in Patients With Rheumatoid Arthritis
January 16th 2025This systematic review of real-world observational studies demonstrated the effectiveness of Janus kinase (JAK) inhibitors in improving treatment adherence, persistence, clinical outcomes, and patient-reported outcomes among US patients with rheumatoid arthritis.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More